Artículos con órdenes de acceso público - Chi-yuan Hsu, MD, MScMás información
No disponibles en ningún lugar: 32
Yes, AKI truly leads to CKD
C Hsu
Journal of the American Society of Nephrology 23 (6), 967-969, 2012
Órdenes: US National Institutes of Health
Some methodological issues in studying the long-term renal sequelae of acute kidney injury
KD Liu, L Lo, C Hsu
Current Opinion in Nephrology and Hypertension 18 (3), 241-245, 2009
Órdenes: US National Institutes of Health
Estimating glomerular filtration rate: is it good enough? And is it time to move on?
DP Murphy, C Hsu
Current opinion in nephrology and hypertension 22 (3), 310-315, 2013
Órdenes: US National Institutes of Health
Long-term outcomes of patients with chronic kidney disease
N Bansal, C Hsu
Nature Clinical Practice Nephrology 4 (10), 532-533, 2008
Órdenes: US National Institutes of Health
In IgA nephropathy, oral methylprednisolone reduced adverse kidney outcomes but increased adverse events
C Hsu, RK Hsu
Annals of Internal Medicine 175 (9), JC105, 2022
Órdenes: National Health and Medical Research Council, Australia, Canadian Institutes …
Higher Plasma ADMA Levels and Lower ADMA and SDMA Fractional Excretion Were Associated With Risk of Atherosclerotic Cardiovascular Disease in Diabetic Kidney Disease: TH-PO238
SJ Schrauben, AH Anderson, C Hsu, JH Ix, T Shafi, M Shlipak, J Chen, ...
Journal of the American Society of Nephrology 33 (11S), 115, 2022
Órdenes: US National Institutes of Health
Baseline and Time-Updated Systolic Blood Pressure and Incident Cognitive Impairment in the Chronic Renal Insufficiency Cohort: TH-OR45
S Babroudi, H Tighiouart, SJ Schrauben, JB Cohen, J He, PS Rao, ...
Journal of the American Society of Nephrology 32 (10S), 13-14, 2021
Órdenes: US National Institutes of Health
In CKD, empagliflozin reduced kidney disease progression at a median 2 y, regardless of primary kidney disease type
JH Hwang, C Hsu
Annals of Internal Medicine 177 (4), JC40, 2024
Órdenes: UK Medical Research Council, Health Data Research, UK
Dialysis Weaning Is Uncommon in the Treatment of Outpatient AKI Requiring Dialysis (AKI-D): SA-OR09
IE McCoy, ED Weinhandl, WF Hussein, C Hsu
Journal of the American Society of Nephrology 34 (11S), 61, 2023
Órdenes: US National Institutes of Health
Association of Post-Hospitalization Vascular Biomarker Clusters with Future Heart Failure: SA-OR07
A Shi, AS Andrawis, W Obeid, AS Go, KD Liu, MM Wurfel, J Himmelfarb, ...
Journal of the American Society of Nephrology 34 (11S), 61, 2023
Órdenes: US National Institutes of Health
Prognostic Comparisons of Carbamylated Albumin and Homocitrulline-Two Circulating Markers of Protein Carbamylation in CKD: TH-PO1075
A Awwad, EP Rhee, M Grams, H Rincon-Choles, JH Sondheimer, J He, ...
Journal of the American Society of Nephrology 34 (11S), 393, 2023
Órdenes: US National Institutes of Health
Initial Outpatient Dialysis Orders in AKI-D vs. ESKD: FR-PO120
IE McCoy, ED Weinhandl, WF Hussein, C Hsu
Journal of the American Society of Nephrology 34 (11S), 439, 2023
Órdenes: US National Institutes of Health
In CKD, once-daily empagliflozin reduced progression of kidney disease or CV death at 2 y
YD Kwong, C Hsu
Annals of Internal Medicine 176 (3), JC26, 2023
Órdenes: US National Institutes of Health, UK Medical Research Council, Health Data …
Original Investigation Subgroups of Patients with Distinct Health Utility Profiles after AKI
YD Kwong, KD Liu, C Hsu, B Cooper, PM Palevsky, JA Kellum, ...
Órdenes: US National Institutes of Health, US Department of Veterans Affairs
Outpatient Recovery From Acute Kidney Injury Requiring Dialysis (ORKID): A Pilot Trial: PUB050
I McCoy, YD Kwong, KD Liu, C Hsu
Journal of the American Society of Nephrology 33 (11S), 897, 2022
Órdenes: US National Institutes of Health
Metabolomics of Uremic Symptoms in CKD: SA-PO931
KE Wulczyn, A Srivastava, J He, T Kelly, AC Ricardo, VO Shah, ...
Journal of the American Society of Nephrology 33 (11S), 862, 2022
Órdenes: US National Institutes of Health
Machine Learning Models Uncover Subphenotypes of AKI With Unique Signatures That Associate With Differing Clinical Outcomes: TH-OR07
G Vasquez-Rios, W Oh, S Lee, PK Bhatraju, S Mansour, DG Moledina, ...
Journal of the American Society of Nephrology 33 (11S), 3, 2022
Órdenes: US National Institutes of Health
Inflammatory Biomarkers and Proteinuria Progression in CKD Patients: The CRIC Study: PO2263
J Chen, LL Hamm, V Batuman, S Geng, JP Lash, C Hsu, PS Rao, ...
Journal of the American Society of Nephrology 32 (10S), 692, 2021
Órdenes: US National Institutes of Health
Considerations in Controlling for Urine Concentration in Performance of Biomarkers of AKI: PO0248
Y Wen, HT Philbrook, DG Moledina, JS Kaufman, WB Reeves, ...
Journal of the American Society of Nephrology 32 (10S), 128-129, 2021
Órdenes: US National Institutes of Health
Non-GFR Determinants of Serum Creatinine and Race in GFR Estimating Equations: Findings from the CRIC Study: PO2323
C Hsu, W Yang, RV Parikh, AH Anderson, TK Chen, DL Cohen, J He, ...
Journal of the American Society of Nephrology 32 (10S), 711, 2021
Órdenes: US National Institutes of Health
La información de publicación y financiación se determina de forma automática mediante un programa informático